Haemonetics Corp. · Corporate Actions

Name: Haemonetics Corp. (HAE) · Tenet stock report
Creator: Tenet Investing
License: https://tenetinvesting.com/methodology

Splits, dividend moves, buybacks and structural changes on file for HAE, and what each one says about how management treats you, the shareholder.

•

Management posture

Returns cash, still building a record

Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.

Annual raise streak

—

no dividend on file

Buyback · FY26

$175.0M

repurchased, latest FY

Last split

2:1

Dec 3, 2012 · forward

Delist / distress

None

no red flags on file

Action history

· 8 on file · newest first

Mar 28, 2026FYBuybackShare repurchases $175M (FY26) $175M Favorable

Mar 29, 2025FYBuybackShare repurchases $225M (FY25) $225M Favorable

Mar 31, 2023FYBuybackShare repurchases $75M (FY23) $75M Favorable

Mar 28, 2020FYBuybackShare repurchases $175M (FY20) $175M Favorable

Mar 30, 2019FYBuybackShare repurchases $160M (FY19) $160M Favorable

Mar 31, 2018FYBuybackShare repurchases $100M (FY18) $100M Favorable

Dec 3, 2012ex-dateSplitForward split 2-for-1 2 : 1 Neutral

Jan 11, 1993ex-dateSplitForward split 2-for-1 2 : 1 Neutral

Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.

Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.

Keep exploringMore in Healthcare

A ABBV ABCL

Data from Intrinio and Financial Modeling Prep.